Analysis of amyloid deposition in a transgenic mouse model of homozygous familial amyloidotic polyneuropathy

American Journal of Pathology

Volumn 150, Issue 4, 1997, Pages 1497-1508

  Kohno, Kyoko ^a   Palha, Joana A ^a,c,h   Miyakawa, Kazuhisa ^d   Saraiva, Maria J M ^b   Ito, Sadahiro ^a   Mabuchi, Tadashi ^a   Blaner, William S ^c   Lijima, Hiroyuki ^c   Tsukahara, Shigeo ^a   Episkopou, Vasso ^a   Gotteshian, Max E ^f   Shimada, Kazunori ^c   Takahashi, Kiyoshi ^g   Yamamura, Ken Ichi ^e   Maeda, Shuichiro ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b UNIVERSITY OF PORTO   (Portugal)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d Institute of Molecular Embryology and Genetics   (Japan)

^e KUMAMOTO UNIVERSITY   (Japan)

^f HAMMERSMITH HOSPITAL   (United Kingdom)

^g OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^h UNIVERSITY INSTITUTE OF HEALTH SCIENCES IUCS   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; PREALBUMIN;

AMINO ACID SUBSTITUTION; AMYLOID NEUROPATHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; FAMILIAL DISEASE; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RACE DIFFERENCE; TRANSGENIC MOUSE;

AMYLOID; AMYLOID NEUROPATHIES; ANIMALS; BLOOD PROTEINS; DISEASE MODELS, ANIMAL; FEMALE; HOMOZYGOTE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PREALBUMIN; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; RETINOL-BINDING PROTEINS; THYROXINE;

EID: 0030971508     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Andrade C: A peculiar form of peripheral neuropathy: familial atypical generalized amyloidosis with special involvement of peripheral nerves. Brain 1952, 75:408-427
2. Saraiva MJM: Transthyretin mutations in health and disease. Hum Mutat 1995, 5:191-196
3. Tawara S, Nakazato M, Kangawa K, Matsuo H, Araki S: Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type), Biochem Biophys Res Commun 1983, 116:880-888
4. Dwulet FE, Benson MD: Primary structure of an amyloid prealbumin and its plasma precursor in a heredofamilial polyneuropathy of Swedish origin. Proc Natl Acad Sci USA 1984, 81:694-698
5. Saraiva MJM, Birken S, Costa PP, Goodman DS: Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type: definition of molecular abnormality in transthyretin (prealbumin). J Clin Invest 1984, 74:104-119
6. Ide M, Mita S, Ikegawa S, Maeda S, Shimada K, Araki S: Identification of carriers of mutant prealbumin gene associated with familial amyloidotic polyneuropathy type I by Southern blot procedures: study of six pedigrees in the Arao district of Japan, Hum Genet 1986, 73:281-285
7. Wakasugi S, Inomoto T, Yi S, Naito M, Uehira M, Iwanaga T, Maeda S, Araki K, Miyazaki J, Takahashi K, Shimada K, Yamamura K: A transgenic mouse model of familial amyloidotic polyneuropathy. Proc Jpn Acad 1987, 63(B):344-347
8. Shimada K, Maeda S, Murakami T, Nishiguchi S, Tashiro F, Yi S, Wakasugi S, Takahashi K, Yamamura K: Transgenic mouse model of familial amyloidotic polyneuropathy. Mol Biol Med 1989, 6:333-343
9. Yi S, Takahashi K, Naito M, Tashiro F, Wakasugi S, Maeda S, Shimada K, Yamamura K, Araki S: Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met 30) gene. Am J Pathol 1991, 138:403-412
10. Blake CCF, Geisow MJ, Swan ID, Rerat C, Rerat B: Structure of human plasma prealbumin at 2.5 Â resolution: a preliminary report on the polypeptide chain conformation, quaternary structure and thyroxine binding, J Mol Biol 1974, 88:1-12
11. Yamamura K, Wakasugi S, Maeda S, Inomoto T, Iwanaga T, Uehira M, Araki K, Miyazaki J, Shimada K: Tissue-specific and developmental expression of human transthyretin gene in transgenic mice, Dev Genet 1987, 8:195-205
12. Episkopou V, Maeda S, Nishiguchi S, Shimada K, Gaitanaris GA, Gottesman ME, Robertson EJ: Disruption of the transthyretin gene results in mice with depressed levels of plasma retinol and thyroid hormone. Proc Natl Acad Sci USA 1993, 90:2375-2379
13. Nagata Y, Tashiro F, Yi S, Murakami T, Maeda S, Takahashi K, Shimada K, Okamura H, Yamamura K: A 6-kb upstream region of the human transthyretin gene can direct developmental, tissue-specific, and quantitatively normal expression in transgenic mouse, J Biochem 1995, 117:169-175
14. Blake CCF, Geisow MJ, Oatley SJ, Rerat B, Rerat C: Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 Å. J Mol Biol 1978, 121:339-356
15. Jaarsveld PP van, Edelhoch H, Goodman DS, Robbins J: The interaction of human plasma retinol-binding protein and prealbumin. J Biol Chem 1973, 248:4698-4705
16. Raz A, Shiratori T, Goodman DS: Studies on the protein-protein and protein-ligand interactions involved in retinot transport in plasma. J Biol Chem 1970, 245: 1903-1912
17. Palha JA, Episkopou V, Maeda S, Shimada K, Gottesman ME, Saraiva MJM: Thyroid hormone metabolism in a transthyretin-null mouse strain. J Biol Chem 1994, 269:33135-33139
18. Wei S, Episkopou V, Piantedosi R, Maeda S, Shimada K, Gottesman ME, Blaner WS: Studies on the metabolism of retinol and retinol-binding protein in transthyretin-deficient mice produced by homologous recombination. J Biol Chem 1995, 270:866-870
19. Isobe S, Nakane PK, Brown WR: Studies on translocation of immunoglobulins across intestinal epithelium. I. Improvements in the peroxidase-labeled antibody method for applications to study of human intestinal mucosa. Acta Histochem Cytochem 1977, 10:161-171
20. Nishiguchi S, Maeda S, Araki S, Shimada K: Structure of the mouse serum amyloid P component gene, Biochem Biophys Res Commun 1988, 155:1366-1373
21. Mita S, Maeda S, Shimada K, Araki S: Cloning and sequence analysis of cDNA for human prealbumin, Biochem Biophys Res Commun 1984, 124:558-564
22. Saraiva MJM, Costa PP, Goodman DS: Transthyretin (prealbumin) in familial amyloidotic polyneuropathy: genetical and functional aspect. Adv Neurol, 1988 48: 201-210
23. Navab M, Smith JE, Goodman DS: Rat plasma prealbumin-metabolic studies on effects of vitamin A status and on tissue contribution. J Biol Chem 1977, 252:5107-5114
24. Furuya H, Saraiva MJM, Gawinowicz MA, Alves IL, Costa PP, Sasaki H, Goto I, Sakaki Y: Production of recombinant human transthyretin with biological activities toward the understanding of the molecular basis of familial amyloidotic polyneuropathy (FAP), Biochemistry 1991, 30:2415-2421
25. Pepys MB, Rademacher TW, Amatayakul-Chantler S, Williams P, Noble GE, Hutchinson WL, Hawkins PN, Nelson SR, Gallimore JR, Herbert J, Mutton T, Dwek RA: Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure. Proc Natl Acad Sci USA 1994, 91:5602-5606
26. Dickson PW, Howlett GJ, Schreiber G: Rat transthyretin (prealbumin): molecular cloning, nucleotide sequence, and gene expression in liver and brain. J Biol Chem 1985, 260:8214-8219
27. Murakami T, Onishi S, Nishiguchi S, Maeda S, Araki S, Shimada K: Acute-phase response of mRNAs for serum amyloid P component, C-reactive protein and prealbumin (transthyretin) in mouse liver. Biochem Biophys Res Commun 1988, 155:554-560
28. McCutchen SL, Lai Z, Miroy GJ, Kelly JW, Colon W: Comparison of lethal and nonlethal transthyretin variants and their relationship to amyloid disease. Biochemistry 1995, 34:13527-13536
29. Alves IL, Saraiva MJM: Comparative catabolism and stability of TTR Met 30 and TTR Met 119. Neuromuscul Disord 1996, 6:S19
30. Holmgren G, Sergstrom S, Drugge U, Lundgren E, Nording-Sikstorm C, Sandgren O, Steen L: Homozygosity for the transthyretin-Met30-gene in seven individuals with familial amyloidosis with polyneuropathy detected by restriction enzyme analysis of amplified genomic DNA sequences. Clin Genet 1992, 41:39-41
31. Yamamura K, Tashiro F, Wakasugi S, Yi S, Maeda S, Shimada K: Transgenic mouse model of autosomal dominant disease: familial amyloidotic polyneuropathy. Molecular Mechanisms of Aging, Edited by K Beyreuther, G Schttler, Heidelberg, Springer-Verlag, 1990, pp 146-154
32. Martone RL, Benson MD, Herbert J: Myelin P2 protein in transthyretin (Ser-84) vitreous amyloid, Amyloid and Amyloidosis 1990. Edited by JB Natvig, Ø Farre, G Husby, A Husebekk, B Skogen, K Sletten, P Westermark. Amsterdam, Kluwer Academic Publishers, 1991, pp 655-658
33. Wadhwani KG, Rapoport SI: Transport properties of vertebrate blood-nerve barrier: comparison with bloodbrain barrier. Prog Neurobiol 1994, 43:235-279
34. Benson MD, Dwulet FE: Identification of carriers of a variant plasma prealbumin (transthyretin) associated with familial amyloidotic polyneuropathy type I. J Clin Invest 1985, 75:71-75
35. Tennent GA, Lovat LB, Pepys MB: Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis. Proc Natl Acad Sci USA 1995, 92:4299-4303
36. Rosen HIM, Moses AC, Murrell JR, Liepnieks JJ, Benson MD: Thyroxine interactions with transthyretin: a comparison of 10 different naturally occurring human transthyretin variants. J Clin Endocrinol Metab 1993, 77:370-374
37. Davis PJ, Spaulding SW, Gregerman RI: The three thyroxine-binding proteins in rat serum: binding capacities and effects of binding inhibitors. Endocrinology 1970, 87:978-986
38. Saraiva MJM, Costa PP, Goodman DS: Studies on plasma transthyretin (prealbumin) in familial amyloidotic polyneuropathy, Portuguese type, J Lab Clin Med 1983, 102:590-603
39. Benson MD, Dwulet FE: Prealbumin and retinol binding protein serum concentrations in the Indiana type hereditary amyloidosis, Arthritis Rheum 1983, 26:1493-1498
40. Dwulet FE, Benson MD: Characterization of a transthyretin (prealbumin) variant associated with familial amyloidotic polyneuropathy type II (Indiana/Swiss), J Clin Invest 1986, 78:880-886
41. Monaco HL, Rizzi M, Coda A: Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein. Science 1995, 268:1039-1041
42. Rask L: The vitamin A transporting system in porcine plasma, Eur J Biochem 1974, 44:1-5
43. Colon W, Kelly JW: Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry 1992, 31:8654-8660